Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection
about
Recent progress in West Nile virus diagnosis and vaccinationFlaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile diseaseFever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public healthRecovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse VirulenceMonoclonal Antibody-Based Competitive Enzyme-Linked Immunosorbent Assay for Detecting and Quantifying West Nile Virus-Neutralizing Antibodies in Horse SeraComplex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses.Single Antigen Detects both Immunoglobulin M (IgM) and IgG Antibodies Elicited by All Four Dengue Virus SerotypesEnzyme-Linked Immunosorbent Assays Using Novel Japanese Encephalitis Virus Antigen Improve the Accuracy of Clinical Diagnosis of Flavivirus InfectionsDengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibodyAttenuated West Nile virus mutant NS1130-132QQA/175A/207A exhibits virus-induced ultrastructural changes and accumulation of protein in the endoplasmic reticulum.Spot the difference-development of a syndrome based protein microarray for specific serological detection of multiple flavivirus infections in travelersB-cell responses during primary and secondary dengue virus infections in humans.A High-Performance Multiplex Immunoassay for Serodiagnosis of Flavivirus-Associated Neurological Diseases in Horses.Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studiesUse of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses.Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex.Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III.Development of an ELISA system for tick-borne encephalitis virus infection in rodents.Improved reliability of serological tools for the diagnosis of West Nile fever in horses within Europe.West Nile virus: characterization and diagnostic applications of monoclonal antibodies.Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli.Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice.ELISA and Neutralization Methods to Measure Anti-West Nile Virus Antibody Responses.Visualization of West Nile Virus in Urine Sediment using Electron Microscopy and Immunogold up to Nine Years Postinfection.
P2860
Q21284433-74776DD2-979D-411D-8B3F-9D409B1139ACQ24273313-76570A4F-6D1A-4308-AC2E-65A608A87A77Q24289308-4C9D4CEB-120D-42BC-9E80-B3058C7FB773Q27469118-0C1EE95E-9179-4654-931D-53A15BD651B4Q27478079-2778A452-9BF6-4577-82A2-5272524EFE89Q27481420-F2A9DE36-542A-48B3-A1B7-AD4799892BEDQ27484622-59CAF846-B3B5-493C-AC8A-DB77CE553ADDQ27486109-3DB903A2-409E-4220-82BB-0C415194D587Q27489654-8A169521-6EBC-4557-8FE8-5270CFE66ED3Q34990985-DDA0C6BB-A465-435B-BFE6-C8FE1905F0B9Q35175842-8CDDE5E1-751C-4006-AC4F-109CF8212985Q35567408-C14F4643-6BA9-4E96-9E63-703F853E4158Q36109311-83180E56-A868-480C-99B2-C2D13FDD6A25Q37271674-6B0E1C99-11B8-4107-B19B-0628D0FFEC34Q37511328-3EDD86A2-BD1F-4BDC-963A-A90C063EA715Q38008644-A3EDE651-417B-4914-98F6-C5108354B21DQ38765315-F36715D3-2841-45B1-B7AD-69410915279EQ39612542-F2499BA8-BAE5-4388-B5AD-CD9EC461C20AQ40038701-99C84CA9-0EA4-4713-B3A2-C5AEAF7B9E6DQ40290346-77BD2D3A-9E29-4B45-8EAE-9C9AD13A7441Q40326193-4E63A2E1-8D47-47EF-AFCB-6555CEDFA6E8Q40340971-717D5762-B51B-4E08-9372-5946E0C426DFQ40671274-0E7DC56D-A830-41E0-AE82-ADF1011E42BDQ45324808-384575C3-07F2-4C17-8E72-DFB6C0C01F63
P2860
Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Use of a recombinant envelope ...... s of West Nile virus infection
@ast
Use of a recombinant envelope ...... s of West Nile virus infection
@en
Use of a recombinant envelope ...... s of West Nile virus infection
@nl
type
label
Use of a recombinant envelope ...... s of West Nile virus infection
@ast
Use of a recombinant envelope ...... s of West Nile virus infection
@en
Use of a recombinant envelope ...... s of West Nile virus infection
@nl
prefLabel
Use of a recombinant envelope ...... s of West Nile virus infection
@ast
Use of a recombinant envelope ...... s of West Nile virus infection
@en
Use of a recombinant envelope ...... s of West Nile virus infection
@nl
P2093
P2860
P50
P1476
Use of a recombinant envelope ...... s of West Nile virus infection
@en
P2093
George V Ludwig
Jose Estrada-Franco
Kathrine Phillippi-Falkenstein
Kristy M Lillibridge
Lark Coffey
Marion S Ratterree
Michael R Holbrook
Robert E Shope
Rudolf P Bohm
P2860
P304
P356
10.1128/JCM.42.6.2759-2765.2004
P407
P50
P577
2004-06-01T00:00:00Z